Our preclinical neuroimaging group investigates novel therapies for depression and Parkinson's disease. Using PET with specific radiolabeled biomarkers, we monitor in vivo molecular changes in translationally relevant rodent and minipig models, focusing on neurotransmission, synaptic plasticity, and neuroinflammation. Current projects explore the therapeutic mechanisms of brain stimulation, ketamine, and inverse GPR6 agonists. Our research also includes behavioral readouts, postmortem analysis, and collaborations on PET biomarker development with radiochemists and industry partners.

I am passionate about fostering positive interactions and sharing knowledge with students and trainees. I have been fortunate to work with bright, talented and diverse young scientists. I have supervised and co-supervised 4 postdoctoral researchers, 12 PhD students, and 17 master’s students. My team regularly hosts medical school interns, offering the opportunity to engage in hands-on experimental work. I specialize in teaching PET imaging and its applications. I deliver lectures in 'Biological Psychiatry’, 'Introduction to Neurodegenerative Disease and Disease Models,' and 'Neurobiology.' I have also contributed to teaching and coordinating the Sino-Danish Center’s 'Molecular Imaging of Brain Structure and Function' course.